Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7141578B2 · kind B2 · utility
6Cited by
114References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2004 |
| Grant date | Nov 28, 2006 |
| Priority date | — |
| Expiry date | Apr 2, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC40B40/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.